# US 2025/0320540 A1 · Point-of-Care Device for the Determination of Creatine Phosphokinase (CPK) in Biological Samples

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0320540 A1
- Document ID: US20250320540A1
- Status: Published application
- Kind: A1
- Application number: 19/250,306
- Filed: 2025-06-26
- Published: 2025-10-16
- Earliest claimed: 2022-12-30
- Assignees: In Vitro Diagnostic Solutions
- Applicants: In Vitro Diagnostic Solutions
- Inventors: Robert Harper; George Temeng; Jordan T. Seville; Matthew DiCerbo
- Web page: https://patentgrep.com/patent/US20250320540A1

## CPC

- C12Q 1/50: involving creatine phosphokinase
- B01L 3/5023: {with a sample being transported to, and subsequently stored in an absorbent for analysis}
- B01L 3/502753: {characterised by bulk separation arrangements on lab-on-a-chip devices, e.g. for filtration or centrifugation}
- G01N 21/78: producing a change of colour
- G01N 21/8483: {Investigating reagent band (test-element handling not specific to a test method G01N33/4875; analytical elements specific to chemical analysis of biological material G01N33/52; autometer with reagent band G01N35/04)}
- G01N 33/54391: {based on vertical flow}
- C12Y 207/03002: Creatine kinase (2.7.3.2)
- G01N 33/525: {Multi-layer analytical elements}
- G01N 2021/775: {Indicator and selective membrane}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12Y: ENZYMES

## Abstract

Devices, kits, and methods for testing and monitoring creatine phosphokinase (CPK) in biological samples are provided.

## Claims

### Claim 1

A device for quantitatively measuring creatinine phosphokinase (CPK) in a biological sample, said device including a test strip comprising:
a sample spreading layer;
a primary whole blood separation membrane;
a secondary whole blood separation membrane; and
a reagent membrane for CPK detection comprising Adenosine 5′-diphosphate (ADP), a creatine phosphate salt, glycerol, 4-aminoantipyrine, a colorimetric redox indicator, an electron mediator, L-α-glycerophosphate oxidase and glycerol kinase.

### Claim 2 (depends on 1)

The device of claim 1, further comprising an electrochemical sensor, light emitting diode (LED) and photodiode, or camera positioned adjacent to the test strip to detect the end-color intensity of the reagent membrane indicative of the CPK concentration in the biological sample.

### Claim 3 (depends on 1)

The device of claim 1, wherein the sample spreading layer comprises a nylon or polyester mesh with a pore size in the range of 10-200 μm that distributes the biological sample laterally and evenly across a surface of the primary whole blood separation membrane.

### Claim 4 (depends on 1)

The device of claim 1, wherein the primary whole blood separation membrane is composed of bound or unbound borosilicate glass microfiber, nylon, polyester, cellulose, cellulose acetate, nitrocellulose, polycarbonate, polyvinylidene difluoride, polyethersulfone or polysulfone or combinations thereof, with an average particle retention size specifically in the range of 3-15 μm.

### Claim 5 (depends on 4)

The device of claim 4, wherein the primary whole blood separation membrane comprises:
a buffer, a non-hemolytic surfactant, a polymer, and hemagglutinating agents to prevent the passage of red blood cells into the reagent membrane; and
an agent that both oxidizes hemoglobin to methemoglobin and oxidizes ascorbate to dehydroascorbate.

### Claim 6 (depends on 1)

The device of claim 1, wherein the secondary whole blood separation membrane is composed of bound or unbound borosilicate glass microfiber, nylon, polyester, cellulose, cellulose acetate, nitrocellulose, polycarbonate, polyvinylidene difluoride, polyethersulfone or polysulfone or combinations thereof, with an average pore size in the range of 0.8-5.0 μm.

### Claim 7 (depends on 6)

The device of claim 6, wherein the secondary whole blood separation membrane is treated with a preconditioning buffer at a concentration of 10-150 mM adjusted to pH 5.0-9.0 and a non-hemolytic surfactant which are both immobilized onto the membrane using a polymer.

### Claim 8 (depends on 1)

The device of claim 1, wherein the reagent membrane is optically smooth and comprised of nylon, cellulose, cellulose acetate, nitrocellulose, polycarbonate, polyethersulfone, polysulfone or combinations thereof, with an average pore size in the range of 0.03-1.2 μm.

### Claim 9 (depends on 8)

The device of claim 8, wherein the reagent membrane is treated with a buffer, surfactant, stabilizers, a colorimetric redox indicator, a cofactor, substrates, enzymes and an electron mediator, all of which are immobilized on the reagent membrane using a polymer.

### Claim 10 (depends on 9)

The device of claim 9, wherein the reagent membrane is buffered to a pH in the range of 5.0-9.0.

### Claim 11 (depends on 9)

The device of claim 9, wherein the electron mediator is peroxidase with an optimum pH activity in the range of 6.0 and 7.0.

### Claim 12 (depends on 11)

The device of claim 11, wherein the peroxidase is derived from Horseradish (Armoracia rusticana) or recombinant derivatives thereof expressed in Escherichia coli.

### Claim 13 (depends on 9)

The device of claim 9, wherein the colorimetric redox indicator is a Trinder reagent coupling with 4-aminoantipyrene (4-AAP) that produces a colored diimine dye upon oxidation, with the diimine dye having a lambda max wavelength between 500 nm and 700 nm.

### Claim 14 (depends on 1)

The device of claim 1, wherein the layer and membranes of the test strip are adhered to a base material through lamination with adhesives or through compression in a cassette.

### Claim 15 (depends on 1)

The device of claim 1, wherein the test strip allows for zero to six percent bias in the hematocrit range of 32-52% through the analytical range of 0-30,000 U/L CPK.

### Claim 16 (depends on 1)

A method for quantitatively measuring creatine phosphokinase (CPK) in a biological sample, said method comprising applying the biological sample to the device of claim 1 and measuring CPK in the biological sample.

### Claim 17 (depends on 16)

The method of claim 16, wherein biological sample applied is less than 25 μL.

### Claim 18 (depends on 16)

The method of claim 16, wherein the reagent membrane of the test strip is positioned facing a light emitting diode (LED) and photodiode to measure the end-color intensity of the reagent membrane indicative of CPK activity in the biological sample.

### Claim 19 (depends on 16)

The method of claim 16, wherein the reagent membrane of the test strip is positioned facing a camera to image the end-color and quantified using Red/Green/Blue (RGB) values.

### Claim 20 (depends on 1)

A kit for detecting creatine phosphokinase (CPK) in a biological sample, said kit comprising a device of claim 1, a means for obtaining a blood sample for testing, a portable hand-held meter for the test strips, and a cell phone application for the quantitative analysis and/or transmitting of data from the test strip to a health care provider.
